Zeitoun, K., Takayama, K., Sasano, H., Suzuki, T., Mograbi, N., Andersson, S., et al. (1998) Deficient 17Beta-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17Beta-Estradiol. Journal of Clinical Endocrinology & Metabolism, 83, 4474-4480.

has been cited by the following article:

• TITLE: Association between mRNA Expression of Aromatase, 17β-HSD2, Level of TGF-β1 and Stage of Endometriosis

  AUTHORS: Ruswana Anwar, Firman F. Wirakusumah, Duddy S. Nataprawira, Ani M. Maskoen, Wiryawan Permadi, Tono Djuwantono

  KEYWORDS: Aromatase, 17βHSD2, TGFβ1, Stage Endometriosis

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.6 No.7, June 16, 2016

  ABSTRACT: Aim: To identify the correlation between mRNA expression of aromatase, 17β-HSD2 level of TGF-β1 and stage of endometriosis. Methods: Case control study was done on 80 patients divided by 40 endometriosis patients and 40 patients as control. mRNA expression of aromatase, mRNA 17β-SD2, was checked using reverse-transcriptase polymerase chain reaction (RT-PCR) and TGF-β1 serum and peritoneal fluid was checked using ELISA. Result: Level of mRNA aromatase from ectopic and eutopic endometrium increased significantly compared to control group (p TGF-β1 on endometriosis group was significantly higher compared to control group (p serum level to endometriosis stage. There are significant correlations between peritoneal fluid TGF-β1 levels to endometriosis stage.